Company intelligence / Profile preview

Lumo Imaging

Salt Lake City, Utah, United Stateslumoscan.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Lumo Imaging is developing advanced, AI-driven total body photography and imaging systems for early skin cancer screening and forensic applications. The company is currently in the R&D stage with no clinical trial results published as of March 2025.

Therapeutic areas: OncologyOther
Modalities: DeviceNon-pharmacological therapy (imaging-based screening and diagnostics)
Industry: Medical Imaging

Beyond the preview

Go deeper on Lumo Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumo Imaging.

Explore the full profile